Clinical Trial Results:
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-
Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of
TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients
with Major Depressive Disorder Who Exhibit an Inadequate Response to
Antidepressant Therapy
Estudio multicéntrico, aleatorizado, doble ciego, de grupos paralelos,
controlado con placebo, de fase III, de eficacia y seguridad en 3 grupos de
dosis fija de TC-5214 (S-mecamilamina) como complemento de un
antidepresivo en pacientes con trastorno depresivo mayor que presentan
una respuesta insuficiente al tratamiento antidepresivo
|
Summary
|
|
EudraCT number |
2010-020140-36 |
Trial protocol |
ES DE SK FR BG HU |
Global completion date |
01 Jan 2012
|
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
09 Sep 2016
|
First version publication date |
09 Sep 2016
|
Other versions |
|
Summary report(s) |
RRF_D4130C00005 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.
